Suppr超能文献

喜树碱负载于空间稳定化磷脂微胶粒:一种新型纳米药物。

Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.

作者信息

Koo Otilia M, Rubinstein Israel, Onyuksel Hayat

机构信息

Department of Biopharmaceutical Sciences, University of Illinois, Chicago, Illinois, USA.

出版信息

Nanomedicine. 2005 Mar;1(1):77-84. doi: 10.1016/j.nano.2004.11.002.

Abstract

BACKGROUND

Camptothecin (CPT) is a well-established topoisomerase I inhibitor against a broad spectrum of cancers. However, poor aqueous solubility, instability, and toxic effects to normal tissues have limited CPT clinical development. Recently, sterically stabilized micelles (SSM) composed of polyethylene glycol (PEGylated) phospholipids have been introduced as safe, biocompatible nanocarriers for the delivery of poorly water-soluble drugs. It was the aim of this study to develop and evaluate in vitro camptothecin-containing SSM (CPT-SSM) as a novel nanomedicine for parenteral administration.

METHODS

The solubilization potential, stability, and in vitro cytotoxicity of CPT in SSM were studied. Lyophilization of CPT-SSM under controlled conditions was also studied.

RESULTS

The mean size of CPT-SSM was found to be approximately 14 nm with a narrow size distribution. CPT-SSM were prepared by coprecipitation reconstitution. At a concentration of 15 mmol/L of PEGylated phospholipids where no micelle-micelle interaction was observed, CPT solubilization in SSM was 25-fold higher than CPT in buffer. We determined that CPT can be solubilized in SSM up to molar ratios of CPT/lipid = 0.0063:1. Above this critical molar ratio, heterogeneous systems of CPT-SSM and CPT self-aggregated particles were formed. CPT in SSM was at least 3 times more stable and 3-fold more cytotoxic to MCF-7 cells than CPT alone. Furthermore, CPT-SSM alone was lyophilized without additional lyoprotectants and cryoprotectants and reconstituted without any significant change in properties.

CONCLUSION

We have shown that CPT in SSM is a promising nanomedicine with improved drug solubility, stability, freeze-drying properties, and anticancer activity. It is anticipated that, because of the nanosize and steric stability of the micelles, CPT-SSM will be passively targeted to solid cancers in vivo, resulting in high drug concentration in tumors and reduced drug toxicity to the normal tissues.

摘要

背景

喜树碱(CPT)是一种公认的拓扑异构酶I抑制剂,可对抗多种癌症。然而,其水溶性差、稳定性不佳以及对正常组织的毒性作用限制了CPT的临床开发。最近,由聚乙二醇(PEG化)磷脂组成的空间稳定化胶束(SSM)已被引入,作为用于递送水溶性差的药物的安全、生物相容性纳米载体。本研究的目的是开发并体外评估含喜树碱的SSM(CPT-SSM)作为一种用于肠胃外给药的新型纳米药物。

方法

研究了CPT在SSM中的增溶潜力、稳定性及体外细胞毒性。还研究了在受控条件下CPT-SSM的冻干情况。

结果

发现CPT-SSM的平均尺寸约为14nm,尺寸分布狭窄。CPT-SSM通过共沉淀重构法制备。在15mmol/L的PEG化磷脂浓度下未观察到胶束-胶束相互作用,CPT在SSM中的溶解度比在缓冲液中高25倍。我们确定CPT在SSM中的溶解度可达CPT/脂质摩尔比为0.0063:1。高于此临界摩尔比,会形成CPT-SSM与CPT自聚集颗粒的异质体系。SSM中的CPT稳定性至少是单独CPT的3倍,对MCF-7细胞的细胞毒性也是单独CPT的3倍。此外,单独的CPT-SSM在没有额外冻干保护剂和冷冻保护剂的情况下进行冻干,并在性质无任何显著变化的情况下重构。

结论

我们已表明,SSM中的CPT是一种有前景的纳米药物,具有改善的药物溶解度、稳定性、冻干性质和抗癌活性。预计由于胶束的纳米尺寸和空间稳定性,CPT-SSM将在体内被动靶向实体癌,从而在肿瘤中产生高药物浓度并降低对正常组织的药物毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验